跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
MOUNJARO tirzepatide 5 mg/0.5 mL solution for injection vial - TGA Drug Approval Details
Approvals
/
TGA
/
MOUNJARO tirzepatide 5 mg/0.5 mL solution for injection vial
Approved
STANDARD
MOUNJARO tirzepatide 5 mg/0.5 mL solution for injection vial
Eli Lilly Australia Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 29, 2025
Approval ID
f18f4f454c3cb8d3
Company
Eli Lilly Australia Pty Ltd
Type
Standard
Approval Details
Approval Id
f18f4f454c3cb8d3
Product Name
MOUNJARO tirzepatide 5 mg/0.5 mL solution for injection vial
Artg Id
407050
Artg Name
MOUNJARO tirzepatide 5 mg/0.5 mL solution for injection vial
Sponsor
Eli Lilly Australia Pty Ltd
Company Detail Path
/organization/eli-lilly-australia-pty-ltd
Artg Date
2023-07-10
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
https://medical-cdn.nocode.com/drug_tga/7aba486418ac447f43670214772ad0c3.pdf
Product Information
https://medical-cdn.nocode.com/drug_tga/527c701de579f37b05e8d2e07895d704.pdf
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 29, 2025
Approval ID
f18f4f454c3cb8d3
Type
Standard
Back to TGA Approvals